 |
|
Recommendation for use of a long-acting monoclonal antibody to prevent respiratory syncytial virus infection in infants and young children
Soo-Han Choi, Dong Hyun Kim, Jong Gyun Ahn, Ki Wook Yun, Byung-Wook Eun, Jin Lee, Jina Lee, Taek-Jin Lee, Hyunju Lee, Dae Sun Jo, Eun Young Cho, Hye-Kyung Cho, Young June Choe, Ui Yoon Choi, Yun-Kyung Kim,
Clin Exp Pediatr. 2025;68(10):742-750. Published online 2025 Sep 3 DOI: https://doi.org/10.3345/cep.2025.01067
|
|
Citations to this article as recorded by
 Effectiveness of Nirsevimab in High-Risk Children Under 24 Months for Prevention of Respiratory Syncytial Virus Infection: A Systematic Review and Meta-Analysis
Ye Kyung Kim, Erdenetuya Bolormaa, Ui Yoon Choi, Hyun Mi Kang, Ji-Man Kang, Joon-sik Choi, Ki Wook Yun, Byung Ok Kwak, Seung-Ah Choe, Young June Choe, Jin Lee, Soo-Han Choi, Yun-Kyung Kim
Journal of Korean Medical Science.2026;[Epub] CrossRef
|